Fobrepodacin
- Generic Name
- Fobrepodacin
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26FN6O6P
- CAS Number
- 1384984-31-9
- Unique Ingredient Identifier
- 1NL76YUU6E
A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Spero Therapeutics
- Target Recruit Count
- 39
- Registration Number
- NCT05966688
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Spero Therapeutics
- Target Recruit Count
- 33
- Registration Number
- NCT05955586
- Locations
- 🇺🇸
Pulmonary Associates, Phoenix, Arizona, United States
Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Phase 2
Terminated
- Conditions
- Mycobacterium Avium ComplexNon-tuberculous Mycobacterium Pulmonary Disease
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Spero Therapeutics
- Target Recruit Count
- 2
- Registration Number
- NCT04553406
- Locations
- 🇺🇸
Medical Facility, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath